Quantification of pancreatic fat with dual-echo imaging at 3.0-T MR in clinical application: how do the corrections for T1 and T2* relaxation effect work and simplified correction strategy

Abstract

Background

Dual-echo imaging is a routine clinical magnetic resonance (MR) sequence affected by T1 and T2* relaxation effect in fat quantification. The separate impacts of T1 and T2* relaxation effect in pancreatic fat quantification using dual-echo imaging at 3.0-T MR have not been reported in detail.

Purpose

To demonstrate the separate T1 and T2* relaxation effect on pancreatic fat quantification by dual-echo imaging at 3.0-T MR and the simplified correction strategy is discussed for convenient clinical application.

Material and Methods

Twenty-one non-alcoholic fatty liver disease (NAFLD) participants with high risk of pancreatic steatosis were included. Pancreatic fat fractions (FF) by dual-echo imaging with different corrections were compared to that of proton magnetic resonance spectroscopy (¹H-MRS). Correlation analysis and Bland–Altman analysis were applied.

Results

The FF by ¹H-MRS was 5.9 ± 1.7%. Significant positive correlation (all P < 0.01) was found between FF by ¹H-MRS and each dual-echo imaging, in which T1 and T2* correction showed the best correlation (r = 0.95, FF = 6.2 ± 1.7%) and no correction showed the worst correlation (r = 0.86, FF = 5.2 ± 2.0%), and the simplified T1 and T2* correction manifested as r = 0.93 and FF = 6.3 ± 1.8%. FF by T1 and T2* correction showed the best agreement, while T1 correction showed the worst agreement as compared to that of ¹H-MRS.

Conclusion

T1 and T2* correction shows the best performance while no correction dual-echo imaging remains clinical available which may benefit from prior OP echo. Simplified correction using single T2* (32.6 ms) of water and fat is recommended for convenient clinical application in absence of obvious pancreatic iron overload.

Keywords

Abdomen/GI magnetic resonance imaging (MRI)pancreas adults technology assessments

Get full access to this article

View all access options for this article.

References

Muoio

Newgard

. Obesity-related derangements in metabolic regulation. Biochemistry 2006; 75: 367–401.

Heilbronn

Smith

Ravussin

. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 2004; 28(Suppl. 4): S12–S21.

Kim

Cho

et al.

Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 2014; 271: 104–112.

Campbell-Tofte

Hansen

et al.

Increased lipids in non-lipogenic tissues are indicators of the severity of type 2 diabetes in mice. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 9–18.

Tushuizen

Bunck

Pouwels

et al.

Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007; 30: 2916–2921.

Thomas

Hamilton

Patel

et al.

Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122–127.

Holalkere

Kambadakone

et al.

Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29: 1253–1277.

Wieckowska

McCullough

Feldstein

. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582–589.

Liska

Dufour

Zern

et al.

Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS One 2007; 2: e569–e569.

10.

Kim

Nayak

et al.

Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010; 18: 841–847.

11.

Cassidy

Yokoo

Aganovic

et al.

Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009; 29: 231–260.

12.

Taouli

Ehman

Reeder

. Advanced MRI methods for assessment of chronic liver disease. Am J Roentgenol 2009; 193: 14–27.

13.

Guiu

Petit

Loffroy

et al.

Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250: 95–102.

14.

Liu

McKenzie

et al.

Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007; 58: 354–364.

15.

Bydder

Yokoo

Hamilton

et al.

Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008; 26: 347–359.

16.

Chebrolu

Hines

et al.

Independent estimation of T*2 for water and fat for improved accuracy of fat quantification. Magn Reson Med 2010; 63: 849–857.

17.

O’Regan

Callaghan

Wylezinska-Arridge

et al.

Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T–feasibility. Radiology 2008; 247: 550–557.

18.

McKenzie

Shimakawa

et al.

Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007; 26: 1153–1161.

19.

Patel

Peterson

Lin

et al.

Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterol Res Pract 2013; 2013: 498296–498296.

20.

De Bazelaire

Duhamel

Rofsky

et al.

MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652–659.

21.

Deoni

Rutt

Peters

. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003; 49: 515–526.

22.

Das

Ray

. Wilson's disease: an update. Nat Clin Pract Neurol 2006; 2: 482–493.

23.

George

Goldwurm

MacDonald

et al.

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311–318.

24.

Leporq

Ratiney

Pilleul

et al.

Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T. Eur Radiol 2013; 23: 2175–2186.

25.

Reeder

Cruite

Hamilton

et al.

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: spcone–spcone.

26.

Song

Yan

. Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0T MR: comparison with single-voxel proton spectroscopy. Chin Med J (Engl) 2014; 127: 3548–3552.

27.

Sijens

Edens

Bakker

et al.

MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010; 16: 1993–1998.

28.

Joe

Lee

Kim

et al.

Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI. J Magn Reson Imaging 2012; 36: 1124–1130.

29.

Hamilton

Middleton

Bydder

et al.

Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009; 30: 145–152.